Integrin αIIbβ3 and shear-dependent action of glycoprotein Ibα stimulate platelet-dependent thrombin formation in stirred plasma

Journal of Laboratory and Clinical Medicine

Volumn 141, Issue 5, 2003, Pages 350-358

  Keuren, Jeffrey F W ^a   Ulrichts, Hans ^b   Feijge, Marion A H ^b   Hamulyak, Karly ^b   Deckmyn, Hans ^b   Lindhout, Theo ^b   Heemskerk, Johan W M ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALPHA2B INTEGRIN; ANTIBODY; BETA3 INTEGRIN; EPITOPE; GLYCOPROTEIN IB; INTEGRIN; PROCOAGULANT; THROMBIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; FIBRINOGEN RECEPTOR; THROMBIN RECEPTOR;

ANTIGEN BINDING; ARTICLE; BLOOD CLOTTING; CASE REPORT; CONTROLLED STUDY; FLUOROMETRY; GLANZMANN DISEASE; HUMAN; HUMAN CELL; NORMAL HUMAN; ROTATION; SHEAR STRESS; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE RICH PLASMA; BIOSYNTHESIS; FLOW CYTOMETRY; METABOLISM; PHYSIOLOGY;

BLOOD COAGULATION; BLOOD PLATELETS; FLOW CYTOMETRY; HUMANS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBIN;

EID: 0038289177     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(03)00004-0     Document Type: Article

References (40)

1. Berndt MC, Shen Y, Dopheide SM, Gardiner EE, Andrews RK. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001;86:178-88.
2. Ruggeri ZM. Platelet-vessel wall interactions in flowing blood. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Haemostasis and thrombosis. Philadelphia: Lippincott, 2001:683-98.
3. Hantgan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot PG. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb/IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990;76:345-53.
4. Endenburg SC, Hantgan RR, Lindeboom-Blokzijl L, Lankhof H, Jerome WG, Lewis JC, et al. On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood. Blood 1995;86:4158-65.
5. Hantgan RR, Taylor RG, Lewis JC. Platelets interact with fibrin only after activation. Blood 1985;65:1299-311.
6. Sanders MW, Nieuwenhuys CMA, Feijge MAH, Rook M, Béguin S, Heemskerk JWM. The procoagulant effect of thrombin on fibrin(ogen)-bound platelets. Haemost 1998;28:289-300.
7. Zaffran Y, Meyer SC, Negrescu E, Reddy KB, Fox JE. Signaling across the platelet adhesion receptor glycoprotein Ib-IX induces αIIbβ3 activation both in platelets and a transfected Chinese hamster ovary cell system. J Biol Chem 2000;275:16779-87.
8. Heemskerk JWM, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002;88:186-93.
9. Kumar R, Béguin S, Hemker HC. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thromb Haemost 1995;74:962-8.
10. Butenas S, Cawthern KM, van't Veer C, DiLorenzo ME, Lock JB, Mann KG. Antiplatelet agents in tissue factor-induced blood coagulation. Blood 2001;97:2314-22.
11. Heemskerk JWM, Siljander PRM, Bevers EM, Farndale RW, Lindhout T. Receptors and signalling mechanisms in the procoagulant response of platelets. Platelets 2000;11:301-6.
12. Dicker IB, Pedicord DL, Seiffert DA, Jamieson GA, Greco NJ. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity. Thromb Haemost 2001;86:1065-9.
13. Keularts IMLW, Béguin S, de Zwaan C, Hemker HC. Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet-rich plasma from patients. Thromb Haemost 1998;80:370-1.
14. Li N, Wallen NH, Savi P, Herault JP, Herbert JM. Effects of a new platelet glycoprotein IIb/IIIa antagonist, SR121566, on platelet activation, platelet-leukocyte interaction and thrombin generation. Blood Coagul Fibrinolysis 1998;9:507-15.
15. Matsumoto Y, Marukawa K, Okumura H, Adachi T, Tani T, Kimura Y. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses. Thromb Res 1999;95:19-29.
16. Lages B, Weiss HJ. Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb-IIIa inhibitors than by peptide and peptidomimetic inhibitors. Br J Haematol 2001;113:65-71.
17. Thomas S, Metcalfe P, Goodall AH, Gray E. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibα inhibit platelet-dependent thrombin generation by different mechanisms. Thromb Haemost 2000;84:98-103.
18. Béguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999;93:564-70.
19. Dörmann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000;96:2469-78.
20. De Candia E, de Cristofaro R, de Marco L, Mazzucato M, Picozzi M, Landolfi R. Thrombin interaction with platelet GPIb: role of the heparin binding domain. Thromb Haemost 1997;77:735-40.
21. Andersen H, Greenberg DL, Fujikawa K, Xu W, Chung DW, Davie EW. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci U S A 1999;96:11189-93.
22. Schoen P, Lindhout T, Franssen J, Hemker HC. Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III, effect of platelet factor 4. Thromb Haemost 1991;66:435-41.
23. Cauwenberghs N, Vanhoorelbeke K, Vauterin S, Westra DF, Romo G, Huizinga EG, et al. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibα. Blood 2001;98:652-60.
24. Cauwenberghs N, Meiring M, Vauterin S, van Wyk V, Lamprecht S, Roodt JP, et al. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in non-human primates. Arterioscler Thromb Vasc Biol 2000;20:1347-53.
25. 2+ responses. Blood 1997;90:2615-25.
26. 3 modulates store-mediated calcium entry in human platelets. Blood 2001;97:2648-56.
27. 2A-Adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J Biol Chem 2000;275:1763-72.
28. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000;83:589-91.
29. Ramjee MK. The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation. Anal Biochem 2000;277:8-11.
30. Hemker HC. Thrombin generation, an essential step in haemostasis and thrombosis. In: Forbes CD, Thomas DP, Tuddenham EGD, eds. Haemostasis and thrombosis. London: Churchill Livingstone, 1993:477-90.
31. Nieuwenhuys CMA, Feijge MAH, Béguin S, Heemskerk JWM. Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma. Thromb Haemost 2000;84:1045-51.
32. Béguin S, Kumar R. Thrombin, fibrin and platelets: a resonance loop in which von Willebrand factor is a necessary link. Thromb Haemost 1997;78:590-4.
33. Hemker HC. The endogenous thrombin potential, a new laboratory parameter to indicate the risk of thrombosis and its diminuation by treatment. In: Siegenthaler W, Haas R, eds. Challenges in medicine. Stuttgart: Thieme Verlag, 1996:104-9.
34. Reverter JC, Béguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody: potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis." J Clin Invest 1996;98:863-74.
35. Plow EF, Cierniewski CS, Xiao ZH, Haas TA, Byzova TV. αIIbβ3 and its antagonism at the new millennium. Thromb Haemost 2001;86:34-40.
36. Coller BS, Anderson K, Weisman HF. New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb Haemost 1995;74:302-8.
37. 3. J Biol Chem 2000;275:41377-88.
38. The EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
39. 3 antagonists under shear stress. XVIIIth Congress of the International Society of Thrombosis and Haemostatsis, Paris, France, 2001.
40. Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983;736:57-66.